Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
While a patient is undergoing anti-CMV therapy, a clinician can use the COBAS AmpliPrep/COBAS TaqMan CMV Test to look for changes in a patient’s CMV viral load. A significant decrease in viral load from one test to the next may indicate that a particular therapy is effective, while an increase or no change may indicate the need for a different therapy.
CMV is a common virus that can cause severe diseases such as pneumonia or colitis in people with weakened immune systems, including solid organ transplant patients.
More Articles on Infections:
TRICARE Patients See Fewer MRSA Infections
Consumer Reports Releases Hospital Safety Ratings
How Hospitals’ Data Transparency Can Spur Quality Improvement
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
